Company Overview of R Bio Co.,Ltd.
R Bio Co., Ltd., a biotechnology company, engages in the research and development of therapeutic agents for diseases with damaged cells and incurable diseases. It develops stem cell drugs; and provides stem cell derived cosmetic ingredients. The company also provides stem cell banking services for future treatment of diseases using adult tissue-derived stem cells. It manages cell banks, such as adipose banks, cord blood banks, and placenta banks. The company was incorporated in 1961 and is headquartered in Seoul, South Korea.
305, Lotte IT Castle Building #2
Founded in 1961
82 2 858 8021
Key Executives for R Bio Co.,Ltd.
R Bio Co.,Ltd. Key Developments
Similar Private Companies By Industry
|Advanced Protein Technologies Corporation||Asia|
|Aetna Genetech Inc.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact R Bio Co.,Ltd., please visit rbio.co.kr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.